Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

Screening drugs to kill cancer cells in their safe spaces

0

Existing chemotherapy approaches treat cancer by targeting cells that are actively multiplying and have a high metabolic rate. However, cancer stem cells can escape this targeting, leading to chemotherapy-resistant cancer and disease relapse. Researchers suspect that the microenvironment in which some cancer stem cells develop may give them protection from chemotherapy treatments. In research described this week in the JCI, a team of researchers led by Trang Hoang at the University of Montreal determined that pre-leukemic stem cells were less sensitive to current chemotherapy drugs. The team then developed a powerful screening method to identify drugs that more effectively target and kill these pre-cancerous cells. They determined that pre-leukemic stem cells were dependent upon specific features in the bone marrow environment for survival. By mimicking these features in a drug screening assay, the researchers were able to identify a compound called 2-methyoxyestradiol that reduced survival of pre-leukemic cells without affecting normal cells. Treatment with 2-methyoxyestradiol also reduced the development of leukemia in a mouse model. The use of this and similar stem cell-targeted screening assays may lead to identification of novel approaches for treating chemotherapy-resistant and relapsed cancer.

###

TITLE: High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells

AUTHOR CONTACT:

Trang Hoang
Institute of Research in Immunology and Cancer – University of Montreal
[email protected]

View this article at: http://www.jci.org/articles/view/86489?key=c884d6b5f99b3e1f6fe1

Media Contact

Elyse Dankoski
[email protected]
@jclinicalinvest

http://www.jci.org

Leave A Reply

Your email address will not be published.